New drugs on the way for goutExperimental compounds control pain and reduce serum uric acid levels Cherries aid gout treatmentConsider concentrated juice as an adjunct to urate-lowering therapy, researcher says Tech refresher: Helping patients get a grip on arthritis First IL-6 receptor inhibitor for rheumatoid arthritis Hoffmann-La Roche will soon be introducing Actemra (tocilizumab), the first interleukin-6 (IL-6) receptor inhibitor to be approved for the treatment of rheumatoid arthritis (RA). Popular assessment tool a poor predictor of cardiovascular risk in rheumatoid arthritis patients Possible link found between rheumatoid arthritis biologics and certain skin cancers Overall risk remains low, but increased incidences seen with anti-tumour necrosis factor drugs Novel drug shows promise in rheumatoid arthritis Predictors of hip disease risk found in juvenile arthritis Rheumatoid arthritis care remains suboptimal Canadian study suggests early, aggressive treatment has not caught on in primary care, especially DMARDs CE Lesson: Update On Rheumatoid Arthritis First Previous 18 19 20 Next Last
